The relationship between early weight loss and weight loss maintenance with naltrexone-bupropion therapy

BACKGROUND: Extended-release (ER) naltrexone/bupropion (NB) was associated with greater weight loss than placebo in four randomized, 56-week trials. The association of NB with longer-term maintenance of weight loss remains unknown. METHODS: We conducted a post-hoc analysis of four phase III, randomi...

Descripción completa

Detalles Bibliográficos
Autores principales: le Roux, Carel W., Fils-Aimé, Nadège, Camacho, Fernando, Gould, Errol, Barakat, Maxime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156890/
https://www.ncbi.nlm.nih.gov/pubmed/35747175
http://dx.doi.org/10.1016/j.eclinm.2022.101436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156890/
https://www.ncbi.nlm.nih.gov/pubmed/35747175
http://dx.doi.org/10.1016/j.eclinm.2022.101436

Ejemplares similares